Sort   by:  
 Page size 
Comparing 4 groups of human subjects: hepatitis B inactive carriers (n = 3), baseline (n = 2), patients receiving telbivudine treatment for 6 months (n = 2), and patients receiving treatment for one year (n = 3).
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size